Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
XLO Xilio Therapeutics
- 1.140
- -0.150-11.63%
Close Feb 14 16:00 ET
- 1.120
- -0.020-1.75%
Post 20:01 ET
52.12MMarket Cap-0.74P/E (TTM)
1.300High1.000Low9.35MVolume1.290Open1.290Pre Close10.85MTurnover42.95%Turnover RatioLossP/E (Static)45.72MShares1.93052wk High2.48P/B24.81MFloat Cap0.55052wk Low--Dividend TTM21.77MShs Float27.950Historical High--Div YieldTTM23.26%Amplitude0.490Historical Low1.160Avg Price1Lot Size
About Xilio Therapeutics Company
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Company Profile
SymbolXLO
Company NameXilio Therapeutics
Listing DateOct 22, 2021
Issue Price16.00
Founded2015
CEODr. Rene Russo, Pharm.D.
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address828 Winter Street,Suite 300
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-524-2466
Websitehttp://www.xiliotx.com
Company Executives
- Name
- Position
- Salary
- Dr. Rene Russo, Pharm.D.
- Director, Chief Executive Officer and President
- 3.00M
- Dr. Katarina Luptakova, M.D.
- Chief Medical Officer
- 932.17K
- Christopher Frankenfield
- Chief Operating Officer
- 1.86M
- Kevin M. Brennan
- Senior Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer
- --
- Paul J. Clancy
- Chairman of the Board
- 96.77K
- Tomas J. Heyman
- Director
- 77.27K
- Robert Ross
- Director
- 66.77K
- Dr. Aoife Brennan, M.D.
- Director
- --
- James Shannon, M.D.
- Director
- --
- Dr. Yuan Xu, PhD
- Director
- 65.77K
- Sara M. Bonstein
- Independent Director
- 76.77K
- Daniel Curran
- Independent Director
- --
- Christina Rossi, M.B.A.
- Independent Director
- 78.05K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.